RATIONALE: Children who are young, malnourished, and infected with HIV have significant risk of tuberculosis (TB) morbidity and mortality following TB infection. Treatment of TB infection is hindered by poor detection and limited pediatric data. OBJECTIVES: Identify improved testing to detect pediatric TB infection. METHODS: This was a prospective community-based study assessing use of the tuberculin skin test and IFN-γ release assays among children (n = 1,343; 6 mo to <15 yr) in TB-HIV high-burden settings; associations with child characteristics were measured. MEASUREMENTS AND MAIN RESULTS: Contact tracing detects TB in 8% of child contacts within 3 months of exposure. Among children with no documented contact, tuberculin skin test and QuantiFERON-TB Gold In-Tube positivity was greater than T-SPOT.TB. Nearly 8% of children had IFN-γ release assay positive and skin test negative discordance. In a model accounting for confounders, all tests correlate with TB contact, but IFN-γ release assays correlate better than the tuberculin skin test (P = 0.0011). Indeterminate IFN-γ release assay results were not associated with age. Indeterminate QuantiFERON-TB Gold In-Tube results were more frequent in children infected with HIV (4.7%) than uninfected with HIV (1.9%), whereas T-SPOT.TB indeterminates were rare (0.2%) and not affected by HIV status. Conversion and reversion were not associated with HIV status. Among children infected with HIV, tests correlated less with contact as malnutrition worsened. CONCLUSIONS: Where resources allow, use of IFN-γ release assays should be considered in children who are young, recently exposed, and infected with HIV because they may offer advantages compared with the tuberculin skin test for identifying TB infection, and improve targeted, cost-effective delivery of preventive therapy. Affordable tests of infection could dramatically impact global TB control.
RATIONALE: Children who are young, malnourished, and infected with HIV have significant risk of tuberculosis (TB) morbidity and mortality following TB infection. Treatment of TB infection is hindered by poor detection and limited pediatric data. OBJECTIVES: Identify improved testing to detect pediatric TB infection. METHODS: This was a prospective community-based study assessing use of the tuberculin skin test and IFN-γ release assays among children (n = 1,343; 6 mo to <15 yr) in TB-HIV high-burden settings; associations with child characteristics were measured. MEASUREMENTS AND MAIN RESULTS: Contact tracing detects TB in 8% of child contacts within 3 months of exposure. Among children with no documented contact, tuberculin skin test and QuantiFERON-TB Gold In-Tube positivity was greater than T-SPOT.TB. Nearly 8% of children had IFN-γ release assay positive and skin test negative discordance. In a model accounting for confounders, all tests correlate with TB contact, but IFN-γ release assays correlate better than the tuberculin skin test (P = 0.0011). Indeterminate IFN-γ release assay results were not associated with age. Indeterminate QuantiFERON-TB Gold In-Tube results were more frequent in children infected with HIV (4.7%) than uninfected with HIV (1.9%), whereas T-SPOT.TB indeterminates were rare (0.2%) and not affected by HIV status. Conversion and reversion were not associated with HIV status. Among children infected with HIV, tests correlated less with contact as malnutrition worsened. CONCLUSIONS: Where resources allow, use of IFN-γ release assays should be considered in children who are young, recently exposed, and infected with HIV because they may offer advantages compared with the tuberculin skin test for identifying TB infection, and improve targeted, cost-effective delivery of preventive therapy. Affordable tests of infection could dramatically impact global TB control.
Authors: S M Hsieh; C C Hung; S C Pan; J T Wang; H C Tsai; M Y Chen; S C Chang Journal: J Acquir Immune Defic Syndr Date: 2000-11-01 Impact factor: 3.731
Authors: Ben J Marais; Robert P Gie; Anneke C Hesseling; H Simon Schaaf; Carl Lombard; Donald A Enarson; Nulda Beyers Journal: Pediatrics Date: 2006-11 Impact factor: 7.124
Authors: Leonardo Martinez; Ye Shen; Ezekiel Mupere; Allan Kizza; Philip C Hill; Christopher C Whalen Journal: Am J Epidemiol Date: 2017-06-15 Impact factor: 4.897
Authors: Lena Ronge; Rosa Sloot; Karen Du Preez; Alexander W Kay; H Lester Kirchner; Harleen M S Grewal; Anna M Mandalakas; Anneke C Hesseling Journal: Pediatr Infect Dis J Date: 2021-08-01 Impact factor: 3.806
Authors: Micaela Sandoval; Padma Swamy; Alexander W Kay; Pilar Ustero Alonso; Gloria Sisi Dube; Hypertia Hlophe-Dlamini; Anna M Mandalakas Journal: Am J Trop Med Hyg Date: 2020-09-24 Impact factor: 3.707
Authors: Irene Andia Biraro; Simon Kimuda; Moses Egesa; Stephen Cose; Emily L Webb; Moses Joloba; Steven G Smith; Alison M Elliott; Hazel M Dockrell; Achilles Katamba Journal: PLoS One Date: 2016-01-15 Impact factor: 3.240